Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia-Pacific Region: A Phase 3 Randomized Controlled Trial.

about

Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia-Pacific Region: A Phase 3 Randomized Controlled Trial.

Item

http://www.wikidata.org/entity/Q41974132

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Efficacy and Safety of Vernaka ...... 3 Randomized Controlled Trial.

@en

type

Item

label

Efficacy and Safety of Vernaka ...... 3 Randomized Controlled Trial.

@en

prefLabel

Efficacy and Safety of Vernaka ...... 3 Randomized Controlled Trial.

@en

P1476

Efficacy and Safety of Vernaka ...... 3 Randomized Controlled Trial.

@en

P2093

Gregory N Beatch

http://www.w3.org/2001/XMLSchema#string

Jörg Rustige

http://www.w3.org/2001/XMLSchema#string

Kiran Bhirangi

http://www.w3.org/2001/XMLSchema#string

Steen Juul-Moller

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years.

Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence.

Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation

An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China.

Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial.

A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.

Low prevalence of atrial fibrillation in community-dwelling Chinese aged 55 years or older in Singapore: a population-based study.

Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation.

A multicenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm.

Pharmacokinetics of novel atrial-selective antiarrhythmic agent vernakalant hydrochloride injection (RSD1235): influence of CYP2D6 expression and other factors.

P304

86-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/FJC.0000000000000445

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27828791

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial

P932

5295492

http://www.w3.org/2001/XMLSchema#string